Staffan Encrantz
Chairman @ Allegro Investment Fund
San Francisco, United States
Staffan Encrantz is a Series A investor at Allegro Investment Fund in San Francisco focused on Eyewear and Health Care. Staffan Encrantz is the founder and Chairman of Allegro Investment Fund, L.P., a registered Cayman Islands Investment Fund that is managed by Allegro Investment Inc. Located in Menlo Park, CA, Allegro primarily invests in growth stage private companies and supports its portfolio by providing growth capital as well as strategic, operating andfinancial expertise. Mr. Encrantz has actively led investments in and operation of a variety of companies for over 30 years. He has led the growth and development of both early stage companies and established businesses in a wide variety of fields. Mr. Encrantz is currently Chairman of AnaMar AB, ClosingCorp Inc, Evolve Controls, LLC, Nclear Inc, Alestra Ltd., Koncentra Holding AB and the Koncentra Verkstads AB group. He is also a director of GovX, Inc, Oxymetal SAS and several other companies.Mr. Encrantz previously worked at ASEA AB, Sweden (now ABB Ltd.), as its deputy General Counsel 1979-1981, as Finance Manager 1981-1984, and during 1984-1990 in Switzerland and the UK as Business Area manager responsible for ABB’s Commodity Trading and Counter Trading group. Prior to this, he worked at Skandia Insurance Co, Sweden as its General Counsel and in private law practice.Mr. Encrantz holds a law degree (Magna cum Laude) from Uppsala University, Sweden.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Staffan Encrantz invests in
Stages Staffan Encrantz invests in
Countries Staffan Encrantz invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Eyewear 1 (50%)
- Health Care 1 (50%)
- Health Diagnostics 1 (50%)
Stage
- Series A 1 (50%)
- Series C 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Sight Sciences is a medical device company that uses a computer-based device designed for the treatment of eye disease. Sight Sciences' devices and non-invasive dry eye products are used for glaucoma procedures or in combination with cataract surgery using the same clear corneal incision, assisting ophthalmologists and optometrists to addressthe underlying physiology of ophthalmic disease.The company's non-surgical Dry Eye product portfolio consists of TearCare which is now commercially available for both ophthalmologists and optometrists. TearCare is a software-controlled, wearable eyelid technology that delivers highly targeted and adjustable heat to the meibomian glands of the eyelids for conditions such as meibomian gland dysfunction and dry eye.It was founded in 2011 and is headquartered in Menlo Park, California, United States. | $10M / Series C / Oct 09, 2017 | ||
| Sight Sciences is a medical device company that uses a computer-based device designed for the treatment of eye disease. Sight Sciences' devices and non-invasive dry eye products are used for glaucoma procedures or in combination with cataract surgery using the same clear corneal incision, assisting ophthalmologists and optometrists to addressthe underlying physiology of ophthalmic disease.The company's non-surgical Dry Eye product portfolio consists of TearCare which is now commercially available for both ophthalmologists and optometrists. TearCare is a software-controlled, wearable eyelid technology that delivers highly targeted and adjustable heat to the meibomian glands of the eyelids for conditions such as meibomian gland dysfunction and dry eye.It was founded in 2011 and is headquartered in Menlo Park, California, United States. | $6.9M / Series A / Oct 30, 2015 |
Co-Investors
About Allegro Investment Fund
Allegro Investment Fund is an open end seed capital investment fund, focussing on high-tech ventures. With a combined experience of more then 40 years of experience in high-tech start-up management, the AIF team adds smart money to your capital needs.
Allegro Investment Fund Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Staffan Encrantz
Chairman
|
|||
Alex Van den Bossche
Co-Founder
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Staffan Encrantz invest in?
Staffan Encrantz invests primarily in Eyewear, Health Care and Health Diagnostics startups, most often at Series A and Series C stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Staffan Encrantz?
Public channels for Staffan Encrantz include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Staffan Encrantz last invest?
The most recent investment recorded for Staffan Encrantz closed in Oct 2017. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
